Solid Biosciences Inc Debt / Equity
Cos'è Debt / Equity di Solid Biosciences Inc?
Debt / Equity di Solid Biosciences Inc è 0.30
Qual è la definizione di Debt / Equity?
Il rapporto debito è un rapporto finanziario che indica la proporzione relativa del patrimonio netto e del debito utilizzato per finanziare le attività di una società.
The debt to equity ratio is generally calculated by dividing debt by equity. The D/E ratio is also known as risk, gearing or leverage. The two components are often taken from the firm's balance sheet or statement of financial position (so-called book value), but the ratio may also be calculated using market values for both, if the company's debt and equity are publicly traded, or using a combination of book value for debt and market value for equity financially. Preferred stock can be considered part of debt or equity. Attributing preferred shares to one or the other is partially a subjective decision but will also take into account the specific features of the preferred shares. When used to calculate a company's financial leverage, the debt usually includes only the long-term debt.
Debt / Equity di aziende nel Health Care settore su NASDAQ rispetto a Solid Biosciences Inc
Cosa fa Solid Biosciences Inc?
solid biosciences (solid) is a cambridge, ma based biotech company singularly focused on developing treatments and cures for duchenne muscular dystrophy (dmd). solid combines sharp commercial focus with world-class science to advance promising therapies and is positioned to catalyze therapeutic development across all aspects of the disease. condition-focused, our mandate is comprehensive; improving daily life for patients and attacking the roots of dmd.
Aziende con debt / equity simili a Solid Biosciences Inc
- West Fraser Timber Co ha Debt / Equity di 0.30
- West Fraser Timber Co ha Debt / Equity di 0.30
- Radcom ha Debt / Equity di 0.30
- Lancaster Colony ha Debt / Equity di 0.30
- Ikonics ha Debt / Equity di 0.30
- Riddhi Siddhi Gluco Biols ha Debt / Equity di 0.30
- Solid Biosciences Inc ha Debt / Equity di 0.30
- Infibeam Avenues ha Debt / Equity di 0.30
- TDG Gold ha Debt / Equity di 0.30
- Motif Bio plc ha Debt / Equity di 0.30
- Matinas Biopharma Inc ha Debt / Equity di 0.30
- Sun.King Power Electronics ha Debt / Equity di 0.30
- Yunji ha Debt / Equity di 0.30